293 related articles for article (PubMed ID: 15203179)
1. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
3. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Shankaran M; Yamamoto BK; Gudelsky GA
Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Darvesh AS; Yamamoto BK; Gudelsky GA
J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
[TBL] [Abstract][Full Text] [Related]
6. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.
Darvesh AS; Shankaran M; Gudelsky GA
J Pharmacol Exp Ther; 2002 Apr; 301(1):138-44. PubMed ID: 11907167
[TBL] [Abstract][Full Text] [Related]
8. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
9. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
Wallinga AE; Grahlmann C; Granneman RA; Koolhaas JM; Buwalda B
Brain Res; 2011 Jun; 1398():13-20. PubMed ID: 21620380
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
12. Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.
Broening HW; Bacon L; Slikker W
J Pharmacol Exp Ther; 1994 Oct; 271(1):285-93. PubMed ID: 7965726
[TBL] [Abstract][Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
14. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
15. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
Capela JP; Fernandes E; Remião F; Bastos ML; Meisel A; Carvalho F
Neurotoxicology; 2007 Jul; 28(4):868-75. PubMed ID: 17572501
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
17. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
Freezer A; Salem A; Irvine RJ
Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
Malberg JE; Sabol KE; Seiden LS
J Pharmacol Exp Ther; 1996 Jul; 278(1):258-67. PubMed ID: 8764359
[TBL] [Abstract][Full Text] [Related]
20. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
Stanley N; Salem A; Irvine RJ
Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
